CytImmune is a biotechnology company that has invented, patented, and developed a set of novel technologies with the potential to treat up to 85% of all cancers. Our IO+ platform turns hot tumors cold, remodels the tumor microenvironment, and kills cancer cells.
Looking for a particular Cytimmune Sciences employee's phone or email?
The Cytimmune Sciences annual revenue was $1 million in 2026.
David Oarr is the President of Cytimmune Sciences.
2 people are employed at Cytimmune Sciences.
Cytimmune Sciences is based in Rockville, Maryland.
The NAICS codes for Cytimmune Sciences are [32541, 3254, 325, 32].
The SIC codes for Cytimmune Sciences are [28, 283].